Neuraminidase inhibitor resistance in influenza: a clinical perspective

Neuraminidase inhibitor resistance in influenza: a clinical perspective

PURPOSE OF REVIEWNeuraminidase inhibitors (NAIs), including oseltamivir, zanamivir, and peramivir, is the main class of antiviral available for clinical use. As such, development of resistance toward these agents is of great clinical and public health concern. RECENT FINDINGSAt present, NAI resistan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in infectious diseases 2018-12, Vol.31 (6), p.520-526
Hauptverfasser: Lee, Nelson, Hurt, Aeron C
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PURPOSE OF REVIEWNeuraminidase inhibitors (NAIs), including oseltamivir, zanamivir, and peramivir, is the main class of antiviral available for clinical use. As such, development of resistance toward these agents is of great clinical and public health concern. RECENT FINDINGSAt present, NAI resistance remains uncommon among the circulating viruses (oseltamivir
ISSN:0951-7375
1473-6527
DOI:10.1097/QCO.0000000000000498